IDEXX Laboratories, Inc. logo
IDEXX Laboratories, Inc. (IDXX)
Compare

IDEXX Laboratories, Inc. (IDXX) Earnings Yield: 2.34%

Is IDEXX Laboratories, Inc.’s earnings yield high or low?

IDEXX Laboratories, Inc.'s earnings yield of 2.34% is 21% above its 5-year average of 1.94%, around the middle of its 5-year range (1.10%–2.96%).

The earnings yield for IDEXX Laboratories, Inc. (IDXX) is 2.34% as of Tuesday, June 9, 2026. It is above its 12-month average by 16.42% (2.01%).

IDXX Earnings Yield Chart

IDXX Earnings Yield
2.34%+11.96% 1Y
Zoom

IDXX Average Earnings Yield Chart

IDXX Current vs Average Earnings Yield Chart

IDXX Earnings Yield Metrics

EARNINGS YIELD

2.34%

EARNINGS YIELD AVG TTM

2.01%

EARNINGS YIELD AVG 3Y

2.07%

EARNINGS YIELD AVG 5Y

1.94%

EARNINGS YIELD AVG 10Y

1.81%

EARNINGS YIELD AVG 15Y

2.23%

EARNINGS YIELD AVG 20Y

2.56%

CURRENT VS TTM AVG

+16.42%

CURRENT VS 3Y AVG

+12.86%

CURRENT VS 5Y AVG

+20.76%

CURRENT VS 10Y AVG

+29.00%

CURRENT VS 15Y AVG

+5.11%

CURRENT VS 20Y AVG

-8.64%

IDXX Competitors' Earnings Yield

NAMEMARKET CAPEARNINGS YIELDTTM3Y5Y
IDEXX Laboratories, Inc. (IDXX)2.34%2.01%2.07%1.94%
Humana Inc. (HUM)$43.60B2.57%4.77%4.86%4.86%
Agilent Technologies, Inc. (A)$38.26B3.68%3.44%3.39%3.16%
Zoetis Inc. (ZTS)$34.46B7.34%4.71%3.52%3.07%
Centene Corporation (CNC)$32.69B6.10%11.48%8.92%6.60%
IQVIA Holdings Inc. (IQV)$31.09B4.33%3.95%3.55%3.02%
DexCom, Inc. (DXCM)$30.17B2.99%2.56%1.80%1.31%
Biogen Inc. (BIIB)$29.39B4.69%6.31%5.95%5.80%
Regeneron Pharmaceuticals, Inc. (REGN)$63.48B6.66%6.23%5.12%6.37%
Veeva Systems Inc. (VEEV)$27.37B3.35%2.28%1.91%1.64%

Earnings Yield vs P/E Ratio

Earnings Yield

2.34%

EPS ÷ Price

P/E Ratio

42.7

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

  • It expresses earnings relative to share price as a percentage
  • It can be compared with FCF yield and dividend yield
  • It can be compared with bond yields because both are percentages
  • It is mathematically the inverse of the P/E ratio

IDEXX Laboratories, Inc. Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

IDEXX Laboratories, Inc. Earnings Yield FAQ

What is the earnings yield for IDEXX Laboratories, Inc. (IDXX)?
The earnings yield for IDXX stock is 2.34%.
Is IDEXX Laboratories, Inc.'s earnings yield high or low?
IDEXX Laboratories, Inc.'s earnings yield of 2.34% is 21% above its 5-year average of 1.94%, around the middle of its 5-year range (1.10%–2.96%).
What is the TTM average earnings yield for IDEXX Laboratories, Inc. (IDXX)?
The TTM average earnings yield for IDXX stock is 2.01%.
What is the 3Y average earnings yield for IDEXX Laboratories, Inc. (IDXX)?
The 3Y average earnings yield for IDXX stock is 2.07%.
What is the 5Y average earnings yield for IDEXX Laboratories, Inc. (IDXX)?
The 5Y average earnings yield for IDXX stock is 1.94%.
What is the 10Y average earnings yield for IDEXX Laboratories, Inc. (IDXX)?
The 10Y average earnings yield for IDXX stock is 1.81%.
What is the 15Y average earnings yield for IDEXX Laboratories, Inc. (IDXX)?
The 15Y average earnings yield for IDXX stock is 2.23%.
What is the 20Y average earnings yield for IDEXX Laboratories, Inc. (IDXX)?
The 20Y average earnings yield for IDXX stock is 2.56%.

IDEXX Laboratories, Inc. Earnings Yield History

DATEEARNINGS YIELD
2026-06-092.34%
2026-06-082.42%
2026-06-052.41%
2026-06-042.40%
2026-06-032.42%
2026-06-022.46%
2026-06-012.39%
2026-05-292.41%
2026-05-282.39%
2026-05-272.46%
2026-05-262.43%
2026-05-222.42%
2026-05-212.45%
2026-05-202.45%
2026-05-192.48%
2026-05-182.48%
2026-05-152.56%
2026-05-142.54%
2026-05-132.56%
2026-05-122.54%
2026-05-112.55%
2026-05-082.42%
2026-05-072.37%
2026-05-062.34%
2026-05-052.41%
2026-05-042.32%
2026-05-012.30%
2026-04-302.33%
2026-04-292.36%
2026-04-282.30%
2026-04-272.27%
2026-04-242.31%
2026-04-232.33%
2026-04-222.26%
2026-04-212.30%
2026-04-202.24%
2026-04-172.22%
2026-04-162.29%
2026-04-152.25%
2026-04-142.24%
2026-04-132.28%
2026-04-102.32%
2026-04-092.24%
2026-04-082.21%
2026-04-072.27%
2026-04-062.26%
2026-04-022.29%
2026-04-012.31%
2026-03-312.33%
2026-03-302.35%
2026-03-272.34%
2026-03-262.28%
2026-03-252.27%
2026-03-242.29%
2026-03-232.26%
2026-03-202.26%
2026-03-192.25%
2026-03-182.26%
2026-03-172.23%
2026-03-162.23%
2026-03-132.28%
2026-03-122.29%
2026-03-112.18%
2026-03-102.18%
2026-03-092.14%
2026-03-062.15%
2026-03-052.11%
2026-03-042.01%
2026-03-032.06%
2026-03-022.05%
2026-02-271.99%
2026-02-261.98%
2026-02-251.99%
2026-02-242.01%
2026-02-232.10%
2026-02-202.06%
2026-02-192.00%
2026-02-181.99%
2026-02-172.01%
2026-02-132.00%
2026-02-122.04%
2026-02-111.94%
2026-02-101.95%
2026-02-091.97%
2026-02-061.96%
2026-02-051.96%
2026-02-041.96%
2026-02-031.99%
2026-02-021.97%
2026-01-301.88%
2026-01-291.86%
2026-01-281.83%
2026-01-271.81%
2026-01-261.81%
2026-01-231.82%
2026-01-221.82%
2026-01-211.81%
2026-01-201.84%
2026-01-161.76%
2026-01-151.77%
2026-01-141.77%
2026-01-131.77%
2026-01-121.74%
2026-01-091.77%
2026-01-081.77%
2026-01-071.76%
2026-01-061.78%
2026-01-051.85%
2026-01-021.88%
2025-12-311.86%
2025-12-301.85%
2025-12-291.83%
2025-12-261.83%
2025-12-241.83%
2025-12-231.85%
2025-12-221.80%
2025-12-191.80%
2025-12-181.81%
2025-12-171.81%
2025-12-161.82%
2025-12-151.80%
2025-12-121.79%
2025-12-111.78%
2025-12-101.80%
2025-12-091.80%
2025-12-081.78%
2025-12-051.77%
2025-12-041.76%
2025-12-031.74%
2025-12-021.72%
2025-12-011.73%
2025-11-281.68%
2025-11-261.67%
2025-11-251.64%
2025-11-241.68%
2025-11-211.74%
2025-11-201.83%
2025-11-191.81%
2025-11-181.88%
2025-11-171.89%
2025-11-141.83%
2025-11-131.80%
2025-11-121.77%
2025-11-111.77%
2025-11-101.78%
2025-11-071.78%
2025-11-061.77%
2025-11-051.75%
2025-11-041.75%
2025-11-031.74%
2025-10-311.91%
2025-10-301.91%
2025-10-291.91%
2025-10-281.89%
2025-10-271.85%
2025-10-241.87%
2025-10-231.88%
2025-10-221.90%
2025-10-211.89%
2025-10-201.87%
2025-10-171.89%
2025-10-161.88%
2025-10-151.88%
2025-10-141.89%
2025-10-131.90%
2025-10-101.95%
2025-10-091.91%
2025-10-081.91%
2025-10-071.91%
2025-10-061.91%
2025-10-031.90%
2025-10-021.89%
2025-10-011.94%
2025-09-301.88%
2025-09-291.90%
2025-09-261.90%
2025-09-251.94%
2025-09-241.91%
2025-09-231.85%
2025-09-221.86%
2025-09-191.83%
2025-09-181.83%
2025-09-171.87%
2025-09-161.86%
2025-09-151.86%
2025-09-121.87%
2025-09-111.86%
2025-09-101.88%
2025-09-091.83%
2025-09-081.84%
2025-09-051.87%
2025-09-041.88%
2025-09-031.89%
2025-09-021.88%
2025-08-291.86%
2025-08-281.86%
2025-08-271.87%
2025-08-261.87%
2025-08-251.87%
2025-08-221.86%
2025-08-211.90%
2025-08-201.88%
2025-08-191.89%
2025-08-181.88%
2025-08-151.85%
2025-08-141.84%
2025-08-131.81%
2025-08-121.84%
2025-08-111.84%
2025-08-081.83%
2025-08-071.85%
2025-08-061.92%
2025-08-051.87%
2025-08-041.76%
2025-08-012.02%
2025-07-312.03%
2025-07-301.89%
2025-07-291.89%
2025-07-281.91%
2025-07-251.91%
2025-07-241.97%
2025-07-232.00%
2025-07-222.03%
2025-07-212.08%
2025-07-182.10%
2025-07-172.09%
2025-07-162.08%
2025-07-152.05%
2025-07-142.04%
2025-07-112.03%
2025-07-102.00%
2025-07-092.00%
2025-07-082.01%
2025-07-071.98%
2025-07-031.98%
2025-07-021.99%
2025-07-011.99%
2025-06-302.02%
2025-06-272.04%
2025-06-262.05%
2025-06-252.04%
2025-06-242.04%
2025-06-232.06%
2025-06-202.07%
2025-06-182.08%
2025-06-172.08%
2025-06-162.05%
2025-06-132.07%
2025-06-122.05%
2025-06-112.06%
2025-06-102.06%
2025-06-092.09%
2025-06-062.06%
2025-06-052.07%
2025-06-042.06%
2025-06-032.06%
2025-06-022.10%
2025-05-302.11%
2025-05-292.10%
2025-05-282.10%

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

Westbrook, ME
11,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jonathan J. Mazelsky